Peter Farshid Afsari, DO
Psychiatry · San Luis Obispo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Mark David Levine MD Professional Corporation · 165 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Afsari’s office at (855) 501-1004 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$18,090
Pharmacies billed $18,090 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 116) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
106 generic and fewer than 11 brand-name prescriptions · $18,090 in drug cost · 19 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Bupropion Xl | 17 | $543 | $32 |
Year by year
| 2024 | 116 | 15 | 0% (0) | None | $18,090 |
| 2023 | 63 | 13 | 0% (0) | 0% | $4,460 |
| 2022 | 98 | 11 | 0% (0) | None | $3,291 |
| 2021 | 106 | None | 0% (0) | 0% | $4,037 |
| 2020 | 70 | 12 | 0% (0) | 0% | $2,039 |
| 2019 | 63 | None | 0% (0) | 0% | $1,543 |
| 2018 | 25 | None | 0% (0) | 0% | $584 |
| 2016 | 65 | None | 0% (0) | 20% | $10,835 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Aripiprazole | 11 | $2,155 | $196 |
2022: 4 drugs
| Duloxetine | 11 | $233 | $21 |
| Lorazepam | 16 | $122 | $8 |
| Zolpidem | 17 | $114 | $7 |
| Quetiapine | 13 | $104 | $8 |
2021: 2 drugs
| Lorazepam | 23 | $138 | $6 |
| Zolpidem | 16 | $95 | $6 |
2020: 1 drug
| Lorazepam | 11 | $32 | $3 |
Money from drug and device companies
$62 in 2025
| 2025 | 2 | 3 | None | $62 |
| 2024 | 3 | 4 | None | $76 |
| 2023 | 10 | 12 | None | $257 |
| 2022 | 7 | 15 | None | $247 |
| 2021 | 1 | 3 | None | $48 |
| 2019 | 1 | 4 | None | $37 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Axsome Therapeutics | Auvelity | $34 | 2 payments
|
| Alkermes | Aristada | $28 | 1 payment
|
See all 3 published payments
| Alkermes | Meals · 2025-12-24 | Aristada | $28 |
| Axsome Therapeutics | Meals · 2025-04-30 | Auvelity | $15 |
| Axsome Therapeutics | Meals · 2025-02-20 | Auvelity | $19 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $76
| Axsome Therapeutics | Auvelity | $33 | 2 payments
|
| Alkermes | Aristada | $28 | 1 payment
|
| Bausch Health US | Aplenzin | $15 | 1 payment
|
2023: $257
| Alkermes | Lybalvi | $52 | 2 payments
|
| Supernus Pharmaceuticals | Qelbree | $45 | 2 payments
|
| Teva Pharmaceuticals USA | Austedo | $28 | 1 payment
|
| AbbVie | Vraylar | $23 | 1 payment
|
| Corium | Azstarys | $23 | 1 payment
|
| Bausch Health US | Aplenzin | $21 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $19 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $16 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $16 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $14 | 1 payment
|
2022: $247
| Supernus Pharmaceuticals | Qelbree | $137 | 8 payments
|
| Sunovion Pharmaceuticals | Latuda | $31 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $18 | 1 payment
|
| Almatica Pharma | Gralise | $16 | 1 payment
|
| Alkermes | Aristada | $16 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $15 | 1 payment
|
| Bausch Health US | Aplenzin | $13 | 1 payment
|
2021: $48
| Supernus Pharmaceuticals | Qelbree | $48 | 3 payments
|
2019: $37
| Sunovion Pharmaceuticals | Latuda | $37 | 4 payments
|
Professional record
- NPI
- 1013126143
- Licence
- CA 20A12976
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X); Federal specialty code 2084P0804X (2084P0804X)
- Mailing address
- 3835 N Freeway Blvd, Ste 100, Sacramento, CA, 95834
- NPI first listed
- 2007-05-22
- NPI last updated
- 2018-03-23
This is when the NPI record was last certified, not a medical board exam.